PUBLICACIÓN
A Novel Agonist of the Type 1 Lysophosphatidic Acid Receptor (LPA1), UCM-05194, Shows Efficacy in Neuropathic Pain Amelioration.
2019
DOI
10.1021/acs.jmedchem.9b01287
AUTORES DE LA UEX
PUBLICACIÓN
A Novel Agonist of the Type 1 Lysophosphatidic Acid Receptor (LPA1), UCM-05194, Shows Efficacy in Neuropathic Pain Amelioration.
2019
DOI
10.1021/acs.jmedchem.9b01287
AUTORES DE LA UEX